Tweet A new drug, called PLX4032, has been developed to block a faulty molecule present in cancer cells. It kills the tumorous cells by blocking the activity of the BRAF gene, which is believed to be the cause of the spread of skin cancer. The drug works at the molecular level, representing a seismic shift in cancer treatment. So...
